FDA Approved: VIGABATRIN — Supplemental Application (Edenbridge Pharmaceuticals LLC.)

View source ↗

Summary

FDA approved a supplemental application for Vigabatrin submitted by Edenbridge Pharmaceuticals LLC, authorizing the marketing of the generic Vigabatrin product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Infantile Spasms
• Partial Seizures

Drugs mentioned

• Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)